77605-75-5

Usage

Uses

Used in Pharmaceutical Industry:
1-[2-[(3-Chloro-2-Methylphenyl)aMino]benzoate] β-D-Glucopyranuronic Acid is used as a metabolite in the pharmaceutical industry for its potential role in understanding the metabolism and pharmacokinetics of Tolfenamic acid. This knowledge can be crucial for optimizing drug dosages, minimizing side effects, and improving the overall efficacy of the parent drug.
Used in Research and Development:
In the field of research and development, 1-[2-[(3-Chloro-2-Methylphenyl)aMino]benzoate] β-D-Glucopyranuronic Acid serves as a valuable compound for studying the mechanisms of drug metabolism, particularly in the context of glucuronidation. This can lead to the development of new drugs with improved pharmacological properties and reduced side effects.
Used in Drug Metabolism Studies:
1-[2-[(3-Chloro-2-Methylphenyl)aMino]benzoate] β-D-Glucopyranuronic Acid is used as a model compound in drug metabolism studies to investigate the role of glucuronidation in the biotransformation of various drugs. This can help researchers understand how different factors, such as genetic variations and environmental influences, can affect the metabolism and clearance of drugs in the body.
Used in Toxicology:
In toxicology, 1-[2-[(3-Chloro-2-Methylphenyl)aMino]benzoate] β-D-Glucopyranuronic Acid can be used to study the potential toxic effects of Tolfenamic acid and its metabolites. This information is essential for assessing the safety profile of the drug and identifying any potential risks associated with its use.
Used in Drug Interaction Studies:
1-[2-[(3-Chloro-2-Methylphenyl)aMino]benzoate] β-D-Glucopyranuronic Acid can also be employed in drug interaction studies to evaluate the potential for drug-drug interactions involving Tolfenamic acid. Understanding these interactions can help healthcare professionals make informed decisions about drug combinations and minimize the risk of adverse effects.